Muscle Organoids Reveal Exercise‐Like Contractions Rapidly Promote Muscle Health Via Lamtor1's Signaling to Both AMPK and mTOR
Advanced Science · 2025-12 · 12 (48)
DOI: 10.1002/advs.202505989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.10.2025. Verfasst von Ziyue Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, University of Chinese Academy of Sc…. Hauptthemen laut MEDLINE: Organoids, TOR Serine-Threonine Kinases, Muscle, Skeletal, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Priority Research Program of the Chinese Academy of Sciences, National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Exercise triggers molecular changes in skeletal muscles, but distinguishing immediate responses from secondary inter‐organ interactions in muscle biopsies remains challenging. Here, this study differentiates human embryonic stem cells (hESCs) into induced skeletal muscle (iMusc) cells to identify hypertrophic factors and generates a novel 3D human iMusc organoid model for studying the direct effects of exercise‐like contractions. Transcriptomics profiling reveals iMusc organoids rapidly induced genes associated with calcium signaling, p38/MAPK, EGF/ErbB, and NGF pathways within 1 h, mimicking exercise responses in vivo. Proteomics profiling and in vivo validation reveal rapid activation of both AMPK and mTORC1 signaling, partly through increased Lamtor1 levels, resolving a paradox in exercise biology. Human muscle biopsy analyses reveal Lamtor1 decreases with aging, and increases with exercise. In vivo and organoid experiments both confirm Lamtor1's role in mTORC1‐induced strength and AMPK‐induced lipid metabolism. Overall, this 3D iMusc organoid model provides insights into primary contraction‐induced changes and identifies Lamtor1 as a novel therapeutic target for exercise mimicry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing Institute for Stem Cell and Regenerative Medicine, Bei…
- School of Biological Engineering, Zhuhai Campus of Zunyi Medical University, Guangdong, 519000, P. R. China.
ORCID-Profile: Ng Shyh-Chang
Förderung
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Science and Technology Major Project
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Initiative Scientific Research Program, Institute of Zoology
- Chinese Academy of Sciences
- Space Application System of China Manned Space Program
- CAS Project for Young Scientists in Basic Research
Zitieren
APA
Yao, Z., Jiang, Z., Liu, X., Zhang, L., Guo, S., Chen, Y., Luo, L., Ma, S., Wang, P., & Shyh-Chang, N. (2025). Muscle Organoids Reveal Exercise‐Like Contractions Rapidly Promote Muscle Health Via Lamtor1's Signaling to Both AMPK and mTOR. Advanced Science, 12(48). https://doi.org/10.1002/advs.202505989
Vancouver
Yao Z, Jiang Z, Liu X, Zhang L, Guo S, Chen Y, et al. Muscle Organoids Reveal Exercise‐Like Contractions Rapidly Promote Muscle Health Via Lamtor1's Signaling to Both AMPK and mTOR. Advanced Science. 2025;12(48). doi:10.1002/advs.202505989
BibTeX
@article{Yao2025,
author = {Yao, Ziyue and Jiang, Zongmin and Liu, Xupeng and Zhang, Liping and Guo, Siyu and Chen, Yu and Luo, Lanfang and Ma, Shilin and Wang, Peng and Shyh-Chang, Ng},
title = {Muscle Organoids Reveal Exercise‐Like Contractions Rapidly Promote Muscle Health Via Lamtor1's Signaling to Both AMPK and mTOR},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {48},
doi = {10.1002/advs.202505989}
}
EUVIMED